阿里云首页 > 域名与网站 > 域名服务 > 域名信息查询(WHOIS) > 网站关键词查询结果

 

与 "genentech" 相关网站域名


域名alecensa.com的网站信息

域名alectinib.com的网站信息

  • 网站标题

      ALECENSA® (alectinib) and ALK+ Non-Small Cell Lung Cancer
  • 网站关键字

  • 网站描述

      Learn about ALECENSA® (alectinib), an ALK+ metastatic non-small cell lung cancer treatment. Important Safety Information: What is the most important information I should know about ALECENSA? Everyone reacts differently to treatment with ALECENSA. It’s important to know the most serious and most common side effects with ALECENSA. Your doctor may lower the dose or stop treatment with ALECENSA if any side effects occur. Contact your doctor right away if you have any of the following side effects. ALECENSA may cause serious side effects, including: Liver problems (hepatotoxicity). ALECENSA may cause liver injury. Your doctor will do blood tests at least every 2 weeks for the first 3 months, and then 1 time each month and as needed during treatment with ALECENSA. Tell your doctor right away if you get any of the following signs and symptoms: Feeling tired, Feeling less hungry than usual, Yellowing of your skin or the whites of your eyes, Dark urine, Itchy skin, Nausea or vomiting, Pain on the right side of your stomach area, Bleeding or bruising more easily than normal Lung problems. ALECENSA may cause severe or life-threatening swelling (inflammation) of the lungs during treatment. Symptoms may be similar to those symptoms from lung cancer. Tell your doctor right away if you have any new or worsening symptoms, including: Trouble breathing, Shortness of breath, Cough, Fever, Kidney problems. ALECENSA may cause severe or life-threatening kidney problems. Tell your doctor right away if you have a change in the amount or color of your urine, or if you get new or worsening swelling in your legs or feet. Slow heartbeat (bradycardia). ALECENSA may cause very slow heartbeats that can be severe. Your doctor will check your heart rate and blood pressure during treatment with ALECENSA. Tell your doctor right away if you feel dizzy, lightheaded, or if you faint during treatment with ALECENSA. Tell your doctor if you take any heart or blood pressure medicines. Muscle pain, tenderness, and weakness (myalgia). Muscle problems are common with ALECENSA and can be severe. Your doctor will do blood tests at least every 2 weeks for the first month and as needed during treatment with ALECENSA. Tell your doctor right away if you have any new or worsening signs and symptoms of muscle problems, including unexplained muscle pain or muscle pain that does not go away, tenderness, or weakness. Before you take ALECENSA, tell your doctor about all of your medical conditions, including if you: Have liver problems, Have lung or breathing problems, Have a slow heartbeat, Are pregnant or plan to become pregnant, Are breastfeeding or plan to breastfeed. Tell your doctor about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements. What are the possible side effects of ALECENSA? The most common side effects of ALECENSA include: Tiredness, Constipation, Swelling in your hands, feet, ankles, face, and eyelids, Muscle pain, tenderness, and weakness (myalgia), Low red blood cell count. These are not all of the possible side effects of ALECENSA. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. Please see additional Important Safety Information in full Prescribing Information, including Patient Information.

域名tamiflu.net的网站信息

  • 网站标题

      Flu Prevention Medicine | Tamiflu® (oseltamivir phosphate)
  • 网站关键字

  • 网站描述

      Tamiflu® (oseltamivir phosphate) is an antiviral medicine for treatment of flu in people 2 weeks of age and older and for prevention of flu in people 1 year of age and older. Indications: Tamiflu is a prescription medicine used to treat the flu (influenza) in people 2 weeks of age and older who have had flu symptoms for no more than 2 days. Tamiflu can also reduce the chance of getting the flu in people 1 year and older. Tamiflu does not prevent bacterial infections that may happen with the flu. Tamiflu is not recommended for people with end-stage renal disease (ESRD) who are not receiving dialysis. Tamiflu is not a substitute for an annual flu vaccination. Do not take Tamiflu if you are allergic to oseltamivir phosphate or any of the ingredients in Tamiflu. Important Safety Information: If you have an allergic reaction or a severe rash with Tamiflu, stop taking it and contact your doctor right away. This may be very serious. People with the flu, particularly children and adolescents, may be at an increased risk of seizure, confusion, or abnormal behavior early during their illness. Let your doctor know if you are pregnant, nursing, have heart problems, breathing problems, a weakened immune system (immunocompromised), kidney problems or other medical conditions as Tamiflu may not be right for you. Also tell your doctor about any medications you are taking or if you’ve received a nasal-spray flu vaccine in the past two weeks. The most common side effects are nausea, vomiting, headache and pain. Please see the Tamiflu full Prescribing Information for complete important safety information. You are encouraged to report side effects to Genentech by calling 1-888-835-2555 or to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.

域名racopay.com的网站信息

  • 网站标题

      Rituxan Immunology and ACTEMRA Co-pay Card Program
  • 网站关键字

  • 网站描述

      Find information about the Rituxan Immunology and ACTEMRA Co-pay Card Program to help manage the cost of Actemra® (tocilizumab) and Rituxan® (rituximab). What does Rituxan treat? Rheumatoid arthritis (RA): with another prescription medicine called methotrexate, to reduce the signs and symptoms of moderate to severe active RA in adults, after treatment with at least one other medicine called a tumor necrosis factor (TNF) antagonist has been used and did not work well enough. Granulomatosis with Polyangiitis (GPA) (Wegener´s Granulomatosis) and Microscopic Polyangiitis (MPA): with glucocorticoids, to treat GPA and MPA. People with serious infections should not receive Rituxan. It is not known if Rituxan is safe or effective in children. Important Side Effect Information What is the most important information I should know about Rituxan? Rituxan can cause serious side effects that can lead to death, including: - Infusion Reactions: Infusion reactions are the most common side effect of Rituxan treatment. Serious infusion reactions can happen during your infusion or within 24 hours after your infusion - Severe Skin and Mouth Reactions: painful sores or ulcers on your skin, lips, or in your mouth; blisters, peeling skin, rash, or pustules - Hepatitis B Virus (HBV) Reactivation: If you have had hepatitis B or are a carrier of hepatitis B virus, receiving Rituxan could cause the virus to become an active infection again - Progressive Multifocal Leukoencephalopathy (PML): a rare, serious brain infection caused by the JC virus What should I tell my doctor before receiving Rituxan? Before receiving Rituxan, tell your doctor if you: - Have had a severe infusion reaction to Rituxan in the past - Have a history of other medical conditions including: o Heart problems o Irregular heartbeat o Chest pain o Lung or kidney problems - Have had an infection, currently have an infection, or have a weakened immune system - Have recently been given a vaccine, plan to get a vaccine, or are in contact with someone who is planning to get a vaccine. You should not get certain vaccines before or after receiving Rituxan. Some types of vaccines can spread to people with a weakened immune system and cause serious problems - Have taken Rituxan in the past - Have any other medical conditions - Are pregnant or planning to become pregnant. Talk to your doctor about effective birth control - Are breast-feeding or plan to breast-feed - Are taking any medications, including prescription and nonprescription medicines, vitamins, and herbal supplements. Especially tell your doctor if you take or have taken: o A Tumor Necrosis Factor (TNF) inhibitor medicine o A Disease Modifying Anti-Rheumatic Drug (DMARD) What are the possible side effects of Rituxan? Rituxan can cause serious and life-threatening side effects, including: - Tumor Lysis Syndrome (TLS): TLS is caused by the fast breakdown of cancer cells. TLS can cause you to have kidney failure and the need for dialysis treatment or may cause an abnormal heart rhythm - Serious Infections: Serious infections can happen during and after treatment with Rituxan and can lead to death - Heart Problems: Rituxan may cause chest pain and irregular heartbeats, which may need treatment, or your doctor may decide to stop your treatment with Rituxan - Kidney Problems: especially if you are receiving Rituxan for NHL. Your doctor should do blood tests to check how well your kidneys are working - Stomach and Serious Bowel Problems That Can Sometimes Lead to Death: Tell your doctor right away if you have any stomach area pain during treatment with Rituxan - Low Blood Cell Counts: Your doctor may do blood tests during treatment with Rituxan to check your blood cell counts What are common side effects during treatment with Rituxan? - Infusion reactions - Chills - Infections - Body aches - Tiredness - Low white blood cell counts Other side effects include: - Aching joints during or within hours of receiving an infusion - More frequent upper respiratory tract infections Tell your doctor or healthcare team about any side effect that bothers you or does not go away. These are not all of the possible side effects with Rituxan. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to the FDA at (800) FDA-1088 or http://www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. Please see the Rituxan Medication Guide including Most Serious Side Effects for additional Important Side Effect Information. What does ACTEMRA treat? ACTEMRA is a prescription medicine called an interleukin-6 (IL-6) receptor antagonist. ACTEMRA is used to treat: -Adults with moderately to severely active rheumatoid arthritis (RA) after at least one other medicine called a disease modifying antirheumatic drug (DMARD) has been used and did not work well -Patients with active polyarticular juvenile idiopathic arthritis (PJIA) or active systemic juvenile idiopathic arthritis (SJIA) 2 years of age and older ACTEMRA is not approved for subcutaneous use in people with PJIA or SJIA. Important Side Effect Information Some people have serious infections while taking ACTEMRA, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have died from these infections. Other serious side effects of ACTEMRA include tears (perforation) of the stomach and intestines, changes in blood test results (including low neutrophil count, low platelet count,increase in certain liver function tests, and increase in blood cholesterol levels), hepatitis B infection becoming an active infection again, and nervous system problems. ACTEMRA affects the immune system and may increase your risk of certain cancers. Serious allergic reactions, including death, can happen with ACTEMRA. These reactions may happen with any infusion or injection of ACTEMRA, even if they did not occur with an earlier infusion or injection. If a patient had hives, a rash, or experienced flushing after injecting, he or she should tell a doctor or nurse before his or her next injection. Patients must also tell their doctor if they have had a previous reaction to ACTEMRA. Patients should not take ACTEMRA if they are allergic to it or any of its ingredients. Common side effects with ACTEMRA in patients with RA include upper respiratory tract infections (common cold, sinus infections), headache, increased blood pressure (hypertension), and injection site reactions. Common side effects with ACTEMRA in patients with PJIA or SJIA include upper respiratory tract infections (sinus infections), headache, nasopharyngitis (common cold), and diarrhea. In general, the types of adverse drug reactions in patients with PJIA were consistent with those seen in SJIA patients. Patients must tell their healthcare provider if they plan to become pregnant or are pregnant. It is not known if ACTEMRA will harm an unborn baby. Genentech has a registry for pregnant women who take ACTEMRA. Patients who are pregnant or become pregnant while taking ACTEMRA must contact the registry at 1-877-311-8972 and talk to their healthcare provider. Patients must call their healthcare provider for medical advice about any side effects. You may report side effects to the FDA at 1-800-FDA-1088 or www.FDA.gov/medwatch. You may also report side effects to Genentech at 1-888-835-2555. Please see accompanying full Prescribing Information, including Boxed Warning and Medication Guide, for additional Important Safety Information.

域名probio.com的网站信息

域名lucentis.org的网站信息

  • 网站标题

      Lucentis® (ranibizumab injection) for Wet AMD, DME & RVO
  • 网站关键字

  • 网站描述

      Discover Lucentis®(ranibizumab injection) and the symptoms of wet macular degeneration, diabetic macular edema, and retinal vein occlusion. Who is LUCENTIS for? LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (wAMD), macular edema following retinal vein occlusion (RVO), and diabetic macular edema (DME). What important safety information should I know about LUCENTIS? LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. Some LUCENTIS patients have had detached retinas and serious infections inside the eye. You should not use LUCENTIS if you have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients. Uncommonly, LUCENTIS patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes. Some patients have had increased eye pressure before and within 1 hour of an injection. Serious side effects include inflammation inside the eye and, rarely, problems related to the injection procedure, such as cataracts. These side effects can make your vision worse. The most common eye-related side effects are increased redness in the white of the eye, eye pain, small specks in vision, and increased eye pressure. The most common non–eye-related side effects are nose and throat infections, headache, lung/airway infections, and nausea. If your eye becomes red, sensitive to light, or painful, or if you have a change in vision, call or visit your eye doctor right away. For additional safety information, please talk to your doctor and see the LUCENTIS full prescribing information.

域名lucentis.info的网站信息

  • 网站标题

      Lucentis® (ranibizumab injection) for Wet AMD, DME & RVO
  • 网站关键字

  • 网站描述

      Discover Lucentis®(ranibizumab injection) and the symptoms of wet macular degeneration, diabetic macular edema, and retinal vein occlusion. Who is LUCENTIS for? LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (wAMD), macular edema following retinal vein occlusion (RVO), and diabetic macular edema (DME). What important safety information should I know about LUCENTIS? LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. Some LUCENTIS patients have had detached retinas and serious infections inside the eye. You should not use LUCENTIS if you have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients. Uncommonly, LUCENTIS patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes. Some patients have had increased eye pressure before and within 1 hour of an injection. Serious side effects include inflammation inside the eye and, rarely, problems related to the injection procedure, such as cataracts. These side effects can make your vision worse. The most common eye-related side effects are increased redness in the white of the eye, eye pain, small specks in vision, and increased eye pressure. The most common non–eye-related side effects are nose and throat infections, headache, lung/airway infections, and nausea. If your eye becomes red, sensitive to light, or painful, or if you have a change in vision, call or visit your eye doctor right away. For additional safety information, please talk to your doctor and see the LUCENTIS full prescribing information.

域名lucentis.net的网站信息

  • 网站标题

      Lucentis® (ranibizumab injection) for Wet AMD, DME & RVO
  • 网站关键字

  • 网站描述

      Discover Lucentis®(ranibizumab injection) and the symptoms of wet macular degeneration, diabetic macular edema, and retinal vein occlusion. Who is LUCENTIS for? LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (wAMD), macular edema following retinal vein occlusion (RVO), and diabetic macular edema (DME). What important safety information should I know about LUCENTIS? LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. Some LUCENTIS patients have had detached retinas and serious infections inside the eye. You should not use LUCENTIS if you have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients. Uncommonly, LUCENTIS patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes. Some patients have had increased eye pressure before and within 1 hour of an injection. Serious side effects include inflammation inside the eye and, rarely, problems related to the injection procedure, such as cataracts. These side effects can make your vision worse. The most common eye-related side effects are increased redness in the white of the eye, eye pain, small specks in vision, and increased eye pressure. The most common non–eye-related side effects are nose and throat infections, headache, lung/airway infections, and nausea. If your eye becomes red, sensitive to light, or painful, or if you have a change in vision, call or visit your eye doctor right away. For additional safety information, please talk to your doctor and see the LUCENTIS full prescribing information.

域名lucentis.com的网站信息

  • 网站标题

      Lucentis® (ranibizumab injection) for Wet AMD, DME & RVO
  • 网站关键字

  • 网站描述

      Discover Lucentis®(ranibizumab injection) and the symptoms of wet macular degeneration, diabetic macular edema, and retinal vein occlusion. Who is LUCENTIS for? LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (wAMD), macular edema following retinal vein occlusion (RVO), and diabetic macular edema (DME). What important safety information should I know about LUCENTIS? LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. Some LUCENTIS patients have had detached retinas and serious infections inside the eye. You should not use LUCENTIS if you have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients. Uncommonly, LUCENTIS patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes. Some patients have had increased eye pressure before and within 1 hour of an injection. Serious side effects include inflammation inside the eye and, rarely, problems related to the injection procedure, such as cataracts. These side effects can make your vision worse. The most common eye-related side effects are increased redness in the white of the eye, eye pain, small specks in vision, and increased eye pressure. The most common non–eye-related side effects are nose and throat infections, headache, lung/airway infections, and nausea. If your eye becomes red, sensitive to light, or painful, or if you have a change in vision, call or visit your eye doctor right away. For additional safety information, please talk to your doctor and see the LUCENTIS full prescribing information.

域名hillhousegroup.com的网站信息

域名atezolizumab.com的网站信息

  • 网站标题

      TECENTRIQ™ Urothelial Carcinoma Treatment | HCP
  • 网站关键字

  • 网站描述

      Find information for healthcare professionals about TECENTRIQ™ (atezolizumab) locally advanced, or metastatic urothelial carcinoma treatment. TECENTRIQ Indication(s) Locally Advanced or Metastatic Urothelial Carcinoma (mUC) TECENTRIQ (atezolizumab) is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who: • Have disease progression during or following platinum-containing chemotherapy • Have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy This indication is approved under accelerated approval based on tumor response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials. IMPORTANT SAFETY INFORMATION Serious Adverse Reactions Please refer to the full Prescribing Information for important dose management information specific to adverse reactions. · Immune-related pneumonitis, including fatal cases. Permanently discontinue TECENTRIQ for grade 3 or 4 pneumonitis · Immune-related hepatitis. Immune-mediated hepatitis, including a fatal case, and liver test abnormalities have occurred. Permanently discontinue TECENTRIQ for grade 3 or 4 immune-mediated hepatitis · Immune-related colitis, including a fatal case of diarrhea-associated renal failure. Permanently discontinue TECENTRIQ for grade 4 diarrhea or colitis · Immune-related endocrinopathies. Immune-related thyroid disorders, adrenal insufficiency, hypophysitis, and type 1 diabetes mellitus, including diabetic ketoacidosis, have occurred. Permanently discontinue TECENTRIQ for grade 4 hypophysitis. For specific information on dose modifications, refer to Prescribing Information · Other immune-related adverse reactions. Meningoencephalitis, myasthenic syndrome/myasthenia gravis, Guillain-Barré syndrome, ocular inflammatory toxicity, and pancreatitis, including increases in serum amylase and lipase levels, have occurred. Permanently discontinue TECENTRIQ for any grade of meningitis or encephalitis; or myasthenic syndrome/myasthenia gravis or Guillain-Barré syndrome. Permanently discontinue TECENTRIQ for grade 4 or any grade of recurrent pancreatitis · Infection, including fatal cases. Severe infections, including sepsis, herpes encephalitis, and mycobacterial infection leading to retroperitoneal hemorrhage have occurred · Infusion-related reactions have occurred. Permanently discontinue TECENTRIQ in patients with grade 3 or 4 infusion reactions · Embryo-fetal toxicity. TECENTRIQ can cause fetal harm in pregnant women. Advise females of reproductive potential to use effective contraception during treatment with TECENTRIQ and for at least 5 months after the last dose · Advise female patients not to breastfeed while taking TECENTRIQ and for at least 5 months after the last dose Most Common Adverse Reactions The most common adverse reactions (rate ≥20%) included fatigue, decreased appetite, nausea, urinary tract infection, pyrexia, and constipation. You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at 1-888-835-2555. Please see full Prescribing Information for additional Important Safety Information.

域名cail.cn的网站信息


免责声明:
本页面内容来源于他人发布于网络的公开信息,阿里云不负责其合法性、准确性判断,并不对使用该类信息的结果承担任何法律责任。同时,阿里云提示您审慎判断。


总共记录: 12条, 共1页, 第1页

域名信息查询(WHOIS)